DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT)

DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT) was reported 0 times

These side effects are most commonly reported by patients taking DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT):

# Side effect Count